Literature DB >> 15831826

Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view.

Martin Olivier1, David J Gregory, Geneviève Forget.   

Abstract

The obligate intracellular parasite Leishmania must survive the antimicrobial activities of its host cell, the macrophage, and prevent activation of an effective immune response. In order to do this, it has developed numerous highly successful strategies for manipulating activities, including antigen presentation, nitric oxide and oxygen radical generation, and cytokine production. This is generally the result of interactions between Leishmania cell surface molecules, particularly gp63 and LPG, and less well identified macrophage surface receptors, causing the distortion of specific intracellular signaling cascades. We describe some of the signaling pathways and intermediates that are repressed in infected cells, including JAK/STAT, Ca(2+)-dependent protein kinase C (PKC) isoforms, and mitogen-activated protein kinases (especially ERK1/2), and proteasome-mediated transcription factor degradation. We also discuss protein tyrosine phosphatases (particularly SHP-1), intracellular Ca2+, Ca(2+)-independent PKC, ceramide, and the suppressors of cytokine signaling family of repressors, which are all reported to be activated following infection, and the role of parasite-secreted cysteine proteases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15831826      PMCID: PMC1082797          DOI: 10.1128/CMR.18.2.293-305.2005

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  166 in total

1.  Role of protein kinase C alpha for uptake of unopsonized prey and phagosomal maturation in macrophages.

Authors:  A Holm; K Tejle; T Gunnarsson; K-E Magnusson; A Descoteaux; B Rasmusson
Journal:  Biochem Biophys Res Commun       Date:  2003-03-21       Impact factor: 3.575

2.  Twenty proteins containing a C-terminal SOCS box form five structural classes.

Authors:  D J Hilton; R T Richardson; W S Alexander; E M Viney; T A Willson; N S Sprigg; R Starr; S E Nicholson; D Metcalf; N A Nicola
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

3.  Src kinase activity is regulated by the SHP-1 protein-tyrosine phosphatase.

Authors:  A K Somani; J S Bignon; G B Mills; K A Siminovitch; D R Branch
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

4.  Positive regulation of c-Jun N-terminal kinase and TNF-alpha production but not histamine release by SHP-1 in RBL-2H3 mast cells.

Authors:  Z H Xie; J Zhang; R P Siraganian
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

5.  Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection.

Authors:  L Soong; J C Xu; I S Grewal; P Kima; J Sun; B J Longley; N H Ruddle; D McMahon-Pratt; R A Flavell
Journal:  Immunity       Date:  1996-03       Impact factor: 31.745

6.  Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites.

Authors:  N Courret; E Prina; E Mougneau; E M Saraiva; D L Sacks; N Glaichenhaus; J C Antoine
Journal:  Eur J Immunol       Date:  1999-03       Impact factor: 5.532

7.  Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase.

Authors:  P A Ram; D J Waxman
Journal:  J Biol Chem       Date:  1997-07-11       Impact factor: 5.157

8.  Microbial glycolipids: possible virulence factors that scavenge oxygen radicals.

Authors:  J Chan; T Fujiwara; P Brennan; M McNeil; S J Turco; J C Sibille; M Snapper; P Aisen; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

9.  Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani.

Authors:  D Nandan; R Lo; N E Reiner
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

10.  Colony-stimulating factor-1 stimulates the formation of multimeric cytosolic complexes of signaling proteins and cytoskeletal components in macrophages.

Authors:  Y G Yeung; Y Wang; D B Einstein; P S Lee; E R Stanley
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

View more
  175 in total

1.  Structure determination of glycogen synthase kinase-3 from Leishmania major and comparative inhibitor structure-activity relationships with Trypanosoma brucei GSK-3.

Authors:  Kayode K Ojo; Tracy L Arakaki; Alberto J Napuli; Krishna K Inampudi; Katelyn R Keyloun; Li Zhang; Wim G J Hol; Christophe L M J Verlinde; Ethan A Merritt; Wesley C Van Voorhis
Journal:  Mol Biochem Parasitol       Date:  2010-12-30       Impact factor: 1.759

2.  Differential microbicidal effects of human histone proteins H2A and H2B on Leishmania promastigotes and amastigotes.

Authors:  Yingwei Wang; Yang Chen; Lijun Xin; Stephen M Beverley; Eric D Carlsen; Vsevolod Popov; Kwang-Poo Chang; Ming Wang; Lynn Soong
Journal:  Infect Immun       Date:  2010-12-28       Impact factor: 3.441

3.  Qualitative and quantitative immunohistochemical evaluation of iNOS expression in the spleen of dogs naturally infected with Leishmania chagasi.

Authors:  Fernando Rocha dos Santos; Paula Melo Abreu Vieira; Rodrigo Correa-Oliveira; Rodolfo Cordeiro Giunchetti; Claudia Martins Carneiro; Alexandre Barbosa Reis; Luiz Cosme Cotta Malaquias
Journal:  Parasitol Res       Date:  2010-12-29       Impact factor: 2.289

4.  Oxidant generation by single infected monocytes after short-term fluorescence labeling of a protozoan parasite.

Authors:  Haeok K Chang; Colin Thalhofer; Breck A Duerkop; Joanna S Mehling; Shilpi Verma; Kenneth J Gollob; Roque Almeida; Mary E Wilson
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

5.  Activation of phosphatidylinositol 3-kinase/Akt and impairment of nuclear factor-kappaB: molecular mechanisms behind the arrested maturation/activation state of Leishmania infantum-infected dendritic cells.

Authors:  Bruno Miguel Neves; Ricardo Silvestre; Mariana Resende; Ali Ouaissi; Joana Cunha; Joana Tavares; Inês Loureiro; Nuno Santarém; Ana Marta Silva; Maria Celeste Lopes; Maria Teresa Cruz; Anabela Cordeiro da Silva
Journal:  Am J Pathol       Date:  2010-10-29       Impact factor: 4.307

6.  Leishmania donovani-induced ceramide as the key mediator of Akt dephosphorylation in murine macrophages: role of protein kinase Czeta and phosphatase.

Authors:  Ranadhir Dey; Nivedita Majumder; Surajit Bhattacharjee; Suchandra Bhattacharyya Majumdar; Rajdeep Banerjee; Sandipan Ganguly; Pradeep Das; Subrata Majumdar
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

7.  Leishmania major abrogates gamma interferon-induced gene expression in human macrophages from a global perspective.

Authors:  Nisha Dogra; Corinna Warburton; W Robert McMaster
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

8.  Cysteine proteinases from promastigotes of Leishmania (Viannia) braziliensis.

Authors:  Karina M Rebello; Luzia M C Côrtes; Bernardo A S Pereira; Bernardo M O Pascarelli; Suzana Côrte-Real; Léa C Finkelstein; Rosa T Pinho; Claudia M d'Avila-Levy; Carlos R Alves
Journal:  Parasitol Res       Date:  2009-09-24       Impact factor: 2.289

9.  Targeted extracellular signal-regulated kinase activation mediated by Leishmania amazonensis requires MP1 scaffold.

Authors:  Paola M Boggiatto; Pedro A Martinez; Ashok Pullikuth; Douglas E Jones; Bryan Bellaire; Andrew Catling; Christine Petersen
Journal:  Microbes Infect       Date:  2014-01-22       Impact factor: 2.700

10.  Leishmania-encoded orthologs of macrophage migration inhibitory factor regulate host immunity to promote parasite persistence.

Authors:  Thomas Holowka; Tiago M Castilho; Alvaro Baeza Garcia; Tiffany Sun; Diane McMahon-Pratt; Richard Bucala
Journal:  FASEB J       Date:  2016-03-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.